1 |
A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3)Gong, Siming, Duan, Yingjuan, Wu, Changwu, Osterhoff, Georg, Schopow, Nikolas, Kallendrusch, Sonja 23 January 2024 (has links)
The overexpression of the enzymes involved in the degradation of procollagen lysine is
correlated with various tumor entities. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3)
expression was found to be correlated to the progression and migration of cancer cells in gastric,
lung and prostate cancer. Here, we analyzed the gene expression, protein expression, and the clinical
parameters of survival across 33 cancers based on the Clinical Proteomic Tumor Analysis Consortium
(CPTAC), function annotation of the mammalian genome 5 (FANTOM5), Gene Expression Omnibus
(GEO), Genotype-Tissue Expression (GTEx), Human Protein Atlas (HPA) and The Cancer Genome
Atlas (TCGA) databases. Genetic alteration, immune infiltration and relevant cellular pathways were
analyzed in detail. PLOD3 expression negatively correlated with survival periods and the infiltration
level of CD8+ T cells, but positively correlated to the infiltration of cancer associated fibroblasts in
diverse cancers. Immunohistochemistry in colon carcinomas, glioblastomas, and soft tissue sarcomas
further confirm PLOD 3 expression in human cancer tissue. Moreover, amplification and mutation
accounted for the largest proportion in esophageal adenocarcinoma and uterine corpus endometrial
carcinoma, respectively; the copy number alteration of PLOD3 appeared in all cancers from TCGA;
and molecular mechanisms further proved the effect of PLOD3 on tumorigenesis. In particular,
PLOD3 expression appears to have a tumor immunological effect, and is related to multiple immune
cells. Furthermore, it is also associated with tumor mutation burden and microsatellite instability in
various tumors. PLOD3 acts as an inducer of various cancers, and it could be a potential biomarker
for prognosis and targeted treatment.
|
2 |
Expression of lysyl hydroxylases and characterization of a novel disorder caused by mutations in the lysyl hydroxylase 3 geneSalo, A. (Antti) 18 August 2009 (has links)
Abstract
Collagens and collagenous proteins undergo several post-translational modifications that are important for their structure and functions. Lysine hydroxylation produces hydroxylysines, which are important for collagen cross-link formation and provide attachment sites for galactose and glucosylgalactose. Glycosylated hydroxylysines are crucial for embryonic development and the assembly of certain collagen types. They may also facilitate interactions between collagen and adjacent molecules as well as control the diameter of collagen fibrils. Lysine hydroxylation is catalyzed by three lysyl hydroxylases (LH1, LH2 and LH3). In addition to lysyl hydroxylase activity, LH3 possesses collagen galactosyltransferase (GT) and glucosyltransferase (GGT) activities.
In this study, polyclonal antibodies against the lysyl hydroxylase isoforms were produced for protein level studies to localize the expression and understand the functions of the different isoenzymes. The results indicated ubiquitous expression during embryonic development compared to the more restricted, cell and tissue specific expression patterns observed in adult mouse tissues. Differences were seen also in the alternative splicing of LH2 during embryogenesis and between tissue types. Analyses of the subcellular localization revealed that LH3 is also present in extracellular space. Tissue and cell specific differences were noted in the distribution of LH3 between cellular compartments. Substrate analysis suggested an additional and novel role for LH3 as an enzyme catalyzing lysine modifications of collagenous proteins in the extracellular space.
The importance of LH1 and LH2 has been highlighted in Ehlers-Danlos type VI and Bruck syndromes, respectively. In this study, the lysyl hydroxylase 3 gene was linked to a heritable disorder for the first time. Urinary screening revealed a patient that lacked a glucosylgalactosyl derivative of a pyridinium cross-link. The GGT activity levels measured from the patient’s serum and lymphoblastoid cells were also reduced, which suggested a defect in the lysyl hydroxylase 3 gene. Genetic analyses revealed two mutations, one in each allele of LH3 in this compound heterozygous patient. Recombinant mutant proteins showed defects in lysyl hydroxylase and collagen glycosyltransferase activities, respectively. In conclusion, it was shown that a defect in LH3 catalyzed modifications leads to a novel disorder, which shares features with many other connective tissue disorders.
|
Page generated in 0.0119 seconds